Comparable stake leader
GOLDENTREE ASSET MANAGEMENT LP
SEC ownership of Keenova Therapeutics plc
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001567892.
Disclosed value leader
GOLDENTREE ASSET MANAGEMENT LP
Comparable rows
11/37
Latest evidence
21 Jul 2026
- Parsed ownership sources
-
3/4/5 and 13D/G
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
GOLDENTREE ASSET MANAGEMENT LP
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
11 of 37
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
GOLDENTREE ASSET MANAGEMENT LP
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
21 Jul 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001567892
- Issuer location
- Dublin 15
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Keenova Therapeutics plc (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
GOLDENTREE ASSET MANAGEME...
Disclosed value leader
GOLDENTREE ASSET MANAGEME...
Comparable rows
11/37
Latest evidence
21 Jul 2026
3/4/5
13D/G
Lead comparable stake: 20%
26 rows are not safely comparable across share classes.
13D/G row: GOLDENTREE ASSET MANAGEMENT LP
Showing 1-8 of 37 holder rows.
Quick read
GOLDENTREE ASSET MANAGEMENT LP leads the comparable SEC ownership view at 20%.
11 of 37 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens GOLDENTREE ASSET MANAGEMENT LP's linked filing trail.
Comparable ownership
Top 5
GOLDENTREE ASSET MANAGEMENT LP
20%
Silver Point Capital L.P.
15%
MARATHON ASSET MANAGEMENT LP
6.8%
Hein Park Capital Management LP
5.5%
Hudson Bay Capital Management LP
5.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 37 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| GOLDENTREE ASSET MANAGEMENT LP |
3/4/5
13D/G
10%+ Owner · Steven A. Tananbaum
|
20%
from 13D/G
|
$736,139,041
7,979,827 shares
|
— | 04 Aug 2025 |
| Silver Point Capital L.P. |
3/4/5
13D/G
10%+ Owner
|
15%
from 13D/G
|
$456,887,866
6,035,214 shares
|
+$67,917,443 | 19 May 2026 |
| MARATHON ASSET MANAGEMENT LP |
13D/G
MARATHON ASSET MANAGEMENT GP, L.L.C.
|
6.8%
|
—
2,710,229 shares
|
$0 | 31 Mar 2026 |
| Hein Park Capital Management LP |
13D/G
|
5.5%
|
—
2,146,733 shares
|
$0 | 31 Dec 2025 |
| Hudson Bay Capital Management LP |
13D/G
|
5.2%
|
—
2,049,739 shares
|
$0 | 31 Dec 2025 |
| James E. Flynn |
13D/G
Deerfield Management Company, L.P.
|
4.1%
|
—
804,259 shares
|
$0 | 31 Mar 2025 |
| Edward A. Mule |
3/4/5
10%+ Owner
|
15%
|
$520,079,117
6,035,214 shares
|
— | 19 May 2026 |
| Robert J. O'Shea |
3/4/5
10%+ Owner
|
15%
|
$520,079,117
6,035,214 shares
|
— | 19 May 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$67,917,442.
Buys
$67,917,442
Insiders: 1
Sells
$0
Insiders: 0
Net
+$67,917,442
Shares: +738,974
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 738,974
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 738,974 | 0 | $67,917,442 | $0 | +$67,917,442 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 55 reporting-owner rows connected to Keenova Therapeutics plc. Open a relationship link for the CIK-to-CIK filing trail.
Rows
55
Largest Forms 3/4/5 holder
GOLDENTREE ASSET MANAGEMENT LP
Net 12M change
+$67,917,443
Latest report
21 Jul 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| GOLDENTREE ASSET MANAGEMENT LP | 10%+ Owner | $736,139,041 | Mixed | 04 Aug 2025 | ||
| Edward A. Mule | 10%+ Owner | $520,079,117 | Mixed | 19 May 2026 | ||
| Robert J. O'Shea | 10%+ Owner | $520,079,117 | Mixed | 19 May 2026 | ||
| Silver Point Capital L.P. | 10%+ Owner | $456,887,866 | +$67,917,443 | +17% | Mixed | 19 May 2026 |
| Alta Fundamental Advisers LLC | 10%+ Owner | $73,015,988 | Mixed | 16 Jun 2023 | ||
| Olafsson Sigurdur O | President and CEO, Director | $2,814,973 | Mixed | 25 Feb 2026 | ||
| Christiana Stamoulis | President and CFO | $1,582,235 | Mixed | 25 Feb 2026 | ||
| David J. Stetson | Director | $1,001,497 | Mixed | 31 Jul 2025 | ||
| Wesley Wheeler | Director | $869,585 | Mixed | 31 Jul 2025 | ||
| Abbas Hussain | Director | $846,230 | Mixed | 31 Jul 2025 | ||
| Paul Efron | Director | $781,319 | Mixed | 15 Jul 2026 | ||
| Lisa French | EVP & Chief Commercial Officer | $744,613 | Mixed | 25 Feb 2026 | ||
| Mark Anthony Tyndall | EVP & CLO and Corp Sec | $724,821 | Mixed | 25 Feb 2026 | ||
| Jon Zinman | Director | $712,751 | Mixed | 15 Jul 2026 | ||
| Henriette Nielsen | EVP & Chief Transformation OFC | $668,998 | Mixed | 25 Feb 2026 | ||
| Leslie E. Donato | Director | $450,365 | Mixed | 15 Jul 2026 | ||
| Bradley Mark T. | EVP, Chief Integration Officer | $371,431 | Mixed | 31 Jul 2025 | ||
| Paul Bisaro | Director | $370,798 | Mixed | 15 Jul 2026 | ||
| Katina Dorton | Director | $222,319 | Mixed | 15 Jul 2026 | ||
| Hugh Paul ONeill | EVP, Chief Operations Officer | $159,928 | Mixed | 25 Feb 2026 |
Recent insider transactions for Keenova Therapeutics plc
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Susan Ann Williamson | Ordinary Shares | Tax liability | -28.1% | -571 | 1,460 | 21 Jul 2026 | Direct | |||
| Tracy Basso | Ordinary Shares | Tax liability | -33.1% | -763 | 1,542 | 21 Jul 2026 | Direct | |||
| Cheryl Ann Stouch | Ordinary Shares | Tax liability | -18.6% | -328 | 1,440 | 21 Jul 2026 | Direct | |||
| Sophia J. Langlois | Restricted Stock Units | Award | 110.6% | 4,406 | 8,390 | 15 Jul 2026 | Direct | |||
| Marc J. Yoskowitz | Restricted Stock Units | Award | 82.9% | 4,406 | 9,718 | 15 Jul 2026 | Direct | |||
| Scott Hirsch | Restricted Stock Units | Award | 110.6% | 4,406 | 8,390 | 15 Jul 2026 | Direct | |||
| Jon Zinman | Restricted Stock Units | Award | 12.7% | 4,406 | 39,078 | 15 Jul 2026 | Direct | |||
| Paul Efron | Restricted Stock Units | Award | 110.6% | 4,406 | 8,390 | 15 Jul 2026 | Direct | |||
| Leslie E. Donato | Restricted Stock Units | Award | 110.6% | 4,406 | 8,390 | 15 Jul 2026 | Direct | |||
| Katina Dorton | Restricted Stock Units | Award | 16.3% | 4,406 | 31,406 | 15 Jul 2026 | Direct | |||
| Paul Bisaro | Restricted Stock Units | Award | 10.4% | 4,406 | 46,749 | 15 Jul 2026 | Direct | |||
| Leslie E. Donato | Ordinary Shares | Tax liability | -23% | -619 | 2,066 | 02 Jun 2026 | Direct | |||
| Leslie E. Donato | Ordinary Shares | Options Exercise | 2,685 | 2,685 | 02 Jun 2026 | Direct | ||||
| Leslie E. Donato | Restricted Stock Units | Options Exercise | -40.3% | -2,685 | 3,984 | 02 Jun 2026 | Direct | |||
| Leslie E. Donato | Restricted Stock Units | Disposed to Issuer | -24.8% | -2,197 | 6,669 | 02 Jun 2026 | Direct | |||
| Sophia D. Langlois | Ordinary Shares | Tax liability | -37% | -1,289 | 2,191 | 02 Jun 2026 | Direct | |||
| Sophia D. Langlois | Ordinary Shares | Options Exercise | 337.7% | 2,685 | 3,480 | 02 Jun 2026 | Direct | |||
| Sophia D. Langlois | Restricted Stock Units | Options Exercise | -40.3% | -2,685 | 3,984 | 02 Jun 2026 | Direct | |||
| Sophia D. Langlois | Restricted Stock Units | Disposed to Issuer | -24.8% | -2,197 | 6,669 | 02 Jun 2026 | Direct | |||
| Scott Hirsch | Ordinary Shares | Tax liability | -19.7% | -619 | 2,521 | 02 Jun 2026 | Direct | |||
| Scott Hirsch | Ordinary Shares | Options Exercise | 590.1% | 2,685 | 3,140 | 02 Jun 2026 | Direct | |||
| Scott Hirsch | Restricted Stock Units | Options Exercise | -40.3% | -2,685 | 3,984 | 02 Jun 2026 | Direct | |||
| Scott Hirsch | Restricted Stock Units | Disposed to Issuer | -24.8% | -2,197 | 6,669 | 02 Jun 2026 | Direct | |||
| Paul Efron | Ordinary Shares | Tax liability | -6.85% | -825 | 11,220 | 02 Jun 2026 | Direct | |||
| Paul Efron | Ordinary Shares | Options Exercise | 42.3% | 3,580 | 12,045 | 02 Jun 2026 | Direct | |||
| Paul Efron | Restricted Stock Units | Options Exercise | -47.3% | -3,580 | 3,984 | 02 Jun 2026 | Direct | |||
| Paul Efron | Restricted Stock Units | Disposed to Issuer | -27.9% | -2,930 | 7,564 | 02 Jun 2026 | Direct | |||
| Katina Dorton | Ordinary Shares | Options Exercise | 194.9% | 4,882 | 7,387 | 02 Jun 2026 | Direct | |||
| Katina Dorton | Restricted Stock Units | Options Exercise | -15.3% | -4,882 | 27,000 | 02 Jun 2026 | Direct | |||
| Paul Bisaro | Ordinary Shares | Tax liability | -9.02% | -619 | 6,244 | 02 Jun 2026 | Direct | |||
| Paul Bisaro | Ordinary Shares | Options Exercise | 64.3% | 2,685 | 6,863 | 02 Jun 2026 | Direct | |||
| Paul Bisaro | Restricted Stock Units | Options Exercise | -5.96% | -2,685 | 42,343 | 02 Jun 2026 | Direct | |||
| Paul Bisaro | Restricted Stock Units | Disposed to Issuer | -4.65% | -2,197 | 45,028 | 02 Jun 2026 | Direct | |||
| Jon Zinman | Ordinary Shares | Options Exercise | 60.8% | 4,882 | 12,913 | 02 Jun 2026 | By JZ Advisors LLC | |||
| Jon Zinman | Restricted Stock Units | Options Exercise | -12.3% | -4,882 | 34,672 | 02 Jun 2026 | Direct | |||
| Marc J. Yoskowitz | Ordinary Shares | Tax liability | -18.9% | -825 | 3,541 | 02 Jun 2026 | Direct | |||
| Marc J. Yoskowitz | Ordinary Shares | Options Exercise | 454.8% | 3,579 | 4,366 | 02 Jun 2026 | Direct | |||
| Marc J. Yoskowitz | Restricted Stock Units | Options Exercise | -40.2% | -3,579 | 5,312 | 02 Jun 2026 | Direct | |||
| Marc J. Yoskowitz | Restricted Stock Units | Disposed to Issuer | -24.8% | -2,930 | 8,891 | 02 Jun 2026 | Direct | |||
| Silver Point Capital L.P. | Common Stock | Purchase | 3.61% | 210,000 | 6,035,214 | 20 May 2026 | Direct | |||
| Silver Point Capital L.P. | Common Stock | Purchase | 3.61% | 210,000 | 6,035,214 | 20 May 2026 | Direct | |||
| Silver Point Capital L.P. | Common Stock | Purchase | 3.61% | 210,000 | 6,035,214 | 20 May 2026 | Direct | |||
| Silver Point Capital L.P. | Common Stock | Purchase | 3.33% | 187,500 | 5,825,214 | 19 May 2026 | Direct | |||
| Silver Point Capital L.P. | Common Stock | Purchase | 3.33% | 187,500 | 5,825,214 | 19 May 2026 | Direct | |||
| Silver Point Capital L.P. | Common Stock | Purchase | 3.33% | 187,500 | 5,825,214 | 19 May 2026 | Direct | |||
| Tracy Basso | Ordinary Shares | Options Exercise | 194.8% | 1,523 | 2,305 | 23 Apr 2026 | Direct | |||
| Tracy Basso | Restricted Stock Units | Options Exercise | -3.16% | -1,523 | 46,717 | 23 Apr 2026 | Direct | |||
| Cheryl Ann Stouch | Ordinary Shares | Options Exercise | 180.2% | 1,137 | 1,768 | 23 Apr 2026 | Direct | |||
| Cheryl Ann Stouch | Restricted Stock Units | Options Exercise | -4.34% | -1,137 | 25,032 | 23 Apr 2026 | Direct | |||
| Susan Ann Williamson | Ordinary Shares | Options Exercise | 179.8% | 1,305 | 2,031 | 23 Apr 2026 | Direct |
* marks a reported price that did not pass the local price check.